Leadership Update: Henry Schein
Stanley M. Bergman retired as Henry Schein CEO at the end of 2025 after a legendary 35+ year tenure during which he grew revenue from $225 million to nearly $13 billion. He continues to serve as Executive Chairman of the Board. Frederick M. Lowery became CEO effective March 2, 2026.
Stanley M. Bergman is one of the most respected leaders in the global healthcare industry. Over 35 years as Chairman and CEO of Henry Schein, Inc. (NASDAQ: HSIC), Bergman transformed the company from a regional dental supply distributor with $225 million in revenue into a Fortune 500 healthcare distribution powerhouse generating nearly $13 billion annually. A South African-born chartered accountant who immigrated to the United States in 1976, Bergman joined Henry Schein in 1980 as CFO and rose to become CEO in 1989. He retired from the CEO role at the end of 2025 and now serves as Executive Chairman of the Board.
(Suggested: Labcorp CEO Email & Net Worth – Adam Schechter)
Stanley Bergman – Quick Facts
Henry Schein Competitors
Henry Schein, Inc. operates in the highly competitive healthcare distribution sector, serving dental, medical, and animal health practitioners worldwide. The company’s key competitors include:
- Patterson Companies, Inc. – Major dental and animal health products distributor
- Benco Dental – One of the largest privately-owned dental distributors in the U.S.
- McKesson Corporation – Healthcare distribution and technology giant
- Owens & Minor – Fortune 500 healthcare logistics and medical supply distributor
- Medline Industries – Major medical supply manufacturer and distributor
- Darby Dental Supply – National dental distributor
Stanley Bergman Net Worth 2026 – Henry Schein CEO Salary
As of 2026, Stanley Bergman’s net worth is estimated at approximately $60 million USD, based primarily on his disclosed Henry Schein stock holdings. Over his 35+ year tenure as CEO, Bergman accumulated a substantial position in HSIC stock, owning approximately 787,508 shares directly.
Stanley Bergman Compensation Breakdown (Fiscal Year 2024)
Henry Schein Net Worth 2026 – Is Henry Schein Profitable?
Yes, Henry Schein is a profitable company and a Fortune 500 member. Under Stanley Bergman’s long-tenured leadership, the company grew from a small regional distributor into a global healthcare products powerhouse.
Henry Schein Financial Summary (FY 2024)
(Recommended: DaVita CEO Email & Net Worth – Javier J. Rodriguez)
Henry Schein CEO Email | Stanley Bergman Contact
Below are the official contact details and social media profiles for Henry Schein Executive Chairman Stanley M. Bergman:
Career & Education – Company, University, & College
Stanley Bergman’s career is one of the most remarkable leadership stories in American healthcare. Born and raised in South Africa, he came to the United States in 1976 and built one of the largest healthcare distribution companies in the world over four decades of dedicated service.
Stanley Bergman Career Timeline
Stanley Bergman graduated from the University of the Witwatersrand in Johannesburg, South Africa, with a Bachelor of Commerce (B.Com.) degree in 1973. He is both a South African Chartered Accountant and a New York State Certified Public Accountant (CPA). After immigrating to the United States in 1976 with his wife Marion, Bergman worked at BDO Seidman providing advisory and consultation services from 1976 to 1980.
In 1980, Bergman joined Henry Schein as Chief Financial Officer and Vice President of Finance and Administration. He rose through the ranks to Executive Vice President before being appointed Chairman and CEO in November 1989, following the unexpected death of Jay Schein, the founder’s son. Under Bergman’s leadership, the company went public in 1995, made over 100 strategic acquisitions, and expanded from a regional dental supply company into a global healthcare distribution powerhouse operating across 33 countries.
(Related: Teladoc Health CEO Email & Net Worth – Jason Gorevic)
Education
Stanley Bergman Wiki – Age, Wife, Family, & More
Stanley M. Bergman (age 76) was born on January 1, 1950, in Port Elizabeth, South Africa. He grew up during the apartheid era, an experience that profoundly shaped his values around diversity, inclusion, and social responsibility. After earning his accounting degree, he met his future wife Dr. Marion Bergman while they were both students at the University of the Witwatersrand in Johannesburg. The couple immigrated together to the United States in 1976.
Stanley and Marion Bergman are passionate philanthropists. Together with their family, they actively support organizations that foster the arts, cultural diversity, grassroots healthcare, higher education, and sustainable entrepreneurial economic development initiatives. Bergman has been recognized by numerous organizations for his leadership and philanthropic contributions, including the American Jewish Committee (AJC), which honored the Bergman family for their global interfaith leadership.
Notable Achievements & Recognitions
- Fortune 500 CEO – Led Henry Schein to Fortune 500 status; company also named to Fortune’s “World’s Most Admired Companies” list
- 35+ Year CEO Tenure – One of the longest-serving CEOs in the S&P 500 index
- World Economic Forum – Regular participant and contributor at Davos
- CEO of the Year – Recognized by multiple industry and business publications
- University of the People – Serves on the leadership team of the tuition-free online university
- CAGR of 17.5% – Grew Henry Schein’s revenue from $225M to ~$13B during his tenure
About Henry Schein, Inc.
Henry Schein, Inc. is a Fortune 500 company and the world’s largest provider of healthcare products and services to office-based dental and medical practitioners. Headquartered in Melville, New York, the company was founded in 1932 by Henry Schein as a corner pharmacy in Queens, New York. Today, the company has operations or affiliates in 33 countries and territories.
Henry Schein distributes dental supplies, medical products, and animal health products. The company also provides technology and practice management solutions that help healthcare professionals run their practices more effectively. In 2024, the company reported $12.67 billion in revenue and employs approximately 25,000 people worldwide. It trades on the NASDAQ under the ticker symbol HSIC.
Frequently Asked Questions (FAQ)
Is Stanley Bergman still the CEO of Henry Schein?
No. Stanley M. Bergman retired as CEO of Henry Schein at the end of 2025 after serving as Chairman and CEO for over 35 years. He continues to serve as Executive Chairman of the Board. Frederick M. Lowery succeeded him as CEO, effective March 2, 2026.
What is Stanley Bergman’s net worth in 2026?
As of 2026, Stanley Bergman’s net worth is estimated at approximately $60 million USD, based primarily on his disclosed Henry Schein stock holdings of approximately 787,508 shares of HSIC stock. Various financial tracking sources estimate his net worth between $48 million and $63 million.
What is Stanley Bergman’s email address?
Stanley Bergman’s email address at Henry Schein is [email protected]. He is also active on LinkedIn at linkedin.com/in/stanbergman. The company’s corporate headquarters is at 135 Duryea Road, Melville, NY 11747.
What was Stanley Bergman’s salary as Henry Schein CEO?
In his final full year as CEO (fiscal year 2024), Stanley Bergman earned total compensation of approximately $11.6 million, which included a $1.69 million base salary, $1.81 million performance bonus, $7.76 million in stock awards, and $371,000 in other compensation.
Who is the new CEO of Henry Schein?
Frederick M. Lowery became the new CEO of Henry Schein effective March 2, 2026. Lowery previously served as Executive Vice President and President of Laboratory Products and BioProduction at Thermo Fisher Scientific. He brings more than two decades of healthcare industry experience to the role.
Article last updated:January 2026March 3, 2026
Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. Net worth figures are estimates based on disclosed stock holdings and may vary by source. This content is provided for informational purposes only and does not constitute financial or investment advice.